Rocket Pharma Says EMA Grants PRIME Designation For RP-A501 Gene Therapy For Danon Disease

RTTNews | 793 days ago
Rocket Pharma Says EMA Grants PRIME Designation For RP-A501 Gene Therapy For Danon Disease

(RTTNews) - Biotechnology company Rocket Pharmaceuticals, Inc. (RCKT) announced Wednesday that the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to RP-A501.

RP-A501 is the Company's investigational adeno-associated virus (AAV)-based gene therapy for the treatment of Danon Disease, a devastating and fatal inherited cardiomyopathy for which there are no curative therapies.

PRIME designation was granted based on positive safety and efficacy data from the Phase 1 clinical trial of RP-A501 in patients with Danon Disease and the potential of RP-A501 to meet the high unmet medical need in this population.

Results from the Phase 1 trial represent one of the most comprehensive investigational gene therapy datasets for any cardiac condition.

For More Such Health News, visit rttnews.com

read more
Bay Street Likely To Open On Weak Note

Bay Street Likely To Open On Weak Note

Canadian shares are set to open on a negative note on Friday as U.S. President Donald Trump's announcement of fresh tariffs on Canada and several other countries has hurt investor sentiment across global markets.
RTTNews | 1h 9min ago
FTSE 100 Down 0.55% As Trump's Tariff Moves Hurt Sentiment

FTSE 100 Down 0.55% As Trump's Tariff Moves Hurt Sentiment

U.K. stocks are down in negative territory on Friday, weighed down by trade concerns after U.S. President Donald Trump announced sweeping tariffs on several countries. The President's letters to 17 major pharma firms, urging them to cut prices, has triggered a sell-off in the pharmaceutical sector.
RTTNews | 2h 18min ago
Eurozone Manufacturing Activity Moves Closer To Stagnation

Eurozone Manufacturing Activity Moves Closer To Stagnation

The euro area manufacturing activity registered a broad stabilization in July as output continued to increase despite a fresh fall in new orders, purchasing managers' survey compiled by S&P Global showed on Friday. The HCOB final manufacturing Purchasing Managers' Index rose to a three-year high of 49.8 in July from 49.5 in June. The score matched the flash estimate.
RTTNews | 3h 11min ago
DAX Down 1.7% As Stocks Tumble On Rising Tariff Concerns

DAX Down 1.7% As Stocks Tumble On Rising Tariff Concerns

German stocks are down sharply on Friday due to heavy selling across the board amid rising trade tensions following U.S. President Donald Trump announcing sharply higher tariffs on dozens of countries, including Canada and Switzerland. Trump also confirmed a 15% tariff on EU imports.
RTTNews | 3h 46min ago